FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/09/045207 [Registered on: 05/09/2022] Trial Registered Prospectively
Last Modified On: 30/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Hypertensive heart disease Hypertension induced left ventricular hypertrophy 
Scientific Title of Study   “A DOUBLE BLIND RCT STUDY TO EVALUATE THE EFFICACY OF CHATUSHPARNI CHURNA RASAYANA AND SARPAGANDHA YOGA IN HRUD VYASA(LEFT VENRICULAR HYPERTROPHY) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kanchana Sharagar 
Designation  Pg Scholar 
Affiliation  Taranath Government Ayurvedic Medical College And Hospital,Ballari 
Address  Taranath Government Ayurvedic Medical College And Hospital,Ballari
Taranath Government Ayurvedic Medical College And Hospital,Dr Rajkumar Road,Ballari
Bellary
KARNATAKA
583101
India 
Phone  9686707603  
Fax    
Email  kanchusharagar123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Madhava Diggavi 
Designation  MD Ayu(Jamnagar)  
Affiliation  Taranath Government Ayurvedic Medical College And Hospital,Ballari 
Address  Taranath Government Ayurvedic Medical College And Hospital,Ballari
Taranath Government Ayurvedic Medical College And Hospital,Ballari
Bellary
KARNATAKA
583101
India 
Phone  9844094290  
Fax    
Email  drmvdbly@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kanchana Sharagar 
Designation  Pg Scholar 
Affiliation  Taranath Government Ayurvedic Medical College And Hospital,Ballari 
Address  Taranath Government Ayurvedic Medical College And Hospital,Ballari
Taranath Government Ayurvedic Medical College And Hospital,Ballari
Bellary
KARNATAKA
583101
India 
Phone  9686707603  
Fax    
Email  kanchusharagar123@gmail.com  
 
Source of Monetary or Material Support  
Taranath Government Ayurvedic Medical College And Hospital,Ballari 
 
Primary Sponsor  
Name  Taranath Government Ayurvedic Medical College And HospitalBallari 
Address  Taranath Government Ayurvedic Medical College And Hospital,Ballari 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kanchana Sharagar  Taranath Government ayurvedic Medical College And Hospital,Ballari  Taranath Government Ayurvedic Medical College And Hospital,Ballari
Bellary
KARNATAKA 
9686707603

kanchusharagar123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
TGAMCIEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I119||Hypertensive heart disease withoutheart failure. Ayurveda Condition: HRUDVYASA, (2) ICD-10 Condition:I119||Hypertensive heart disease withoutheart failure. Ayurveda Condition: Hrudvyasa,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: haritakyadi yoga, Reference: charaka chiktsa, Route: Oral, Dosage Form: Churna/ Powder, Dose: 4(g), Frequency: tds, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: ushna jals), Additional Information: -kosta shodhana
2Comparator ArmDrugClassical(1) Medicine Name: Haritakyadi yoga, Reference: Charaka samhita chikitsa sthana, Route: Oral, Dosage Form: Churna/ Powder, Dose: 4(g), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: -ushna jala), Additional Information: -koshtashodhana
3Comparator ArmDrugClassical(1) Medicine Name: Sarpagandha yogs, Reference: Rasatantra sara, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -dashamooladi kashaya), Additional Information: -rasayana
4Intervention ArmDrugOther than Classical(1) Medicine Name: Chatushparni churna, Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -dashamooladi kashaya), Additional Information: -rasayana
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Diagnosed case of HYPERTENSION and LEFT VENTRICULAR HYPERTROPHY on antihypertensive treatment will be taken.
2. Blood pressure- SBP 150-160mmHg
DBP 90-100mmHg
3. Patients between the age group of 30-65 years.
4. Patients with cornell criteria.
 
 
ExclusionCriteria 
Details  1. CCF
2. Multiorgan failure
3. Ejection fraction < 30%
4. Acute M.I
5. Pregnant and lactating women
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Improvement in Hypertension  8 Weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Left ventricular hypertrophy  09 weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="20" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

NEED FOR THE STUDY

Hrud vyasa is a new technical term composed of Hrudaya and Vyasa. 1 One of  the  Vata prakopa lakshanas is Vyasa, which means asankocha(dilatation). It can happen in any organ or any part of the body, if it happens in Hrudaya it may be considered as Hrud vyasa.

Left ventricular hypertrophy 2 is enlargement and thickening of the walls of the left ventricle. LVH is more common in people who have uncontrolled high blood pressure. If it is left untreated leads to high risk of congestive heart failure and irregular heart rhythms,is present in 15% to 20% of the general population.3 It is often prevelant in blacks,the elderly, the obese, and in patient with Hypertension.

Cardio vascular diseases are leading cause of death globally,  17.9 million people died from Cardio vascular disease in 2019, representing 30% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Inspite of research and development in cardiology, prevention of  LVH in cases of hypertension patients is not satisfactory.Hence there is scope for research in Kayachikitsa and specially Hrudaya Marmaroga. The research question is whether Rasayana chikitsa has a role to play in preventing the development of  LVH in patients of hypertension who are under treatment. A cost effective herbal or herbominerallo mettalic Rasayana is needed in regular practice of preventive ayurvedic cardiology.

Chatushparni is a combination of Shalaparni 4, Prishniparni5, Mudgaparni6, Mashaparni 7 with Madhura, tikta, tridosha hara, Hrudya, Balya, Mutrala and Rasayana effects. By vasodilatation, anti-arrythmic activity and maintenance of HDL and lowering LDL effects reduce the load on heart and improve cardiac muscle and vessel nutrition8 .

Sarpagandha yoga is a combination of Rasasindura and Sarpagandha. Rasasindura 9 acts as Rasayana, sarvavyadhihara, yogavahi, prakrutisthapana, catalyst and target specific action . Sarpagandha 10 is effective in Bhrama, Shoola, Siragatavata and Anidra   also  proven anti-hypertensive11 drug which helps in reducing afterload thus preventing further hypertrophy. The alkaloid Reserpine is useful in hypertension and cardiovascular diseases12. Both of the medicines are not explored for there potent cardiotonic activity and there usefulness in preventive cardiology.The shamana yoga will be double blinded in the present study to reduce the bias.

Hence with the alternate hypothesis  a herbal hrudya yoga Chatushparni Rasayana and A Herbo-mineral Yoga Sarpagandha yoga is effective in reducing Hrud Vyasa (Hypertension Induced Left Ventricular Hypertrophy) has been taken with the title

“A DOUBLE BLIND RCT STUDY TO EVALUATE THE EFFICACY OF CHATUSHPARNI RASAYANA AND SARPAGANDHA YOGA IN HRUD VYASA(HYPERTENSION INDUCED LEFT VENTRICULAR HYPERTROPY)”.


Diagnostic Criteria:

ü  Symptoms like Hrutshoola (chest pain),Arohana ayasa (exertional dyspneoa),Pratah shirashoola (early morning headache), Bhrama (Giddiness), Nidra viparyaya(Insomnia), Dourbalya (weakness), Hrudrava (palpitation), Amlodgara (sour belching),Padashopha (pedal oedema), Angamarda (bodyache).

ü  TMT

ü  ECG

ü  2D-ECHOCARDIOGRAPHY - LVH GRADING BY POSTERIOR WALL THICKNESS

-      MILD: 12 to 13mm

-      MODERATE >13 to 17mm

                                                     

Inclusive criteria:

·       Diagnosed case of HYPERTENSION and LEFT VENTRICULAR HYPERTROPHY on antihypertensive treatment will be taken.

·       Blood pressure-           SBP 150-160mmHg

DBP 90-100mmHg

·       Patients between the age group of 30-65 years.

·       Patients with cornell criteria.

Exclusive criteria:

·       Who doesn’t provide informed consent

·       CCF

·       Multiorgan failure

·       Ejection fraction < 30%

·       Acute M.I

·       Pregnant and lactating women


Interventions:

GROUP-A(20 PATIENTS)

·       Deepana pachana & Kosta shodhana with Haritakyadi yoga 4gms with warm water(b/f) TID for 5 to 7 days  or till samyak shodhana .

·       Chatushparni kashaya bhavita Chatushparni  Rasayana 250mg capsule 2 BD before food for 45 days with Dashamuladi Kashaya anupana (15ml kashaya+60 ml warm water).

GROUP-B (20 PATIENTS)

·       Deepana pachana & kosta shodhana with Haritakyadi yoga 4gms with warm water(b/f) TID for 5 to 7 days  or till samyak shodhana .

·       Sarpagandha kashaya bhavita Sarpagandha yoga 250mg capsule 2 BD before food for 45 days with Dashamuladi Kashaya anupana (15ml kashaya+60ml warm water).

 

STUDY DESIGN-

ü  PROSPECTIVE DOUBLEBLIND RANDOMIZED CLINICAL TRAIL               

ü   ESTIMATED ENROLLMENT – 40

ü  INTERVENTIONAL MODEL- 2 GROUP ASSIGNMENT

ü  ALLOCATION-RANDOMIZED

ü  MASKING- DOUBLE BLINDED

ü  STUDY DURATION – 55          

ü  FOLLOW UP-AFTER 15 DAYS

 

Assessment criteria:

The Assessment will be made as per special case record format prepared.

On the basis of 2D-Echocardiography and E.C.G before and at the end of the trial.

Based on both subjective and objective parameters.

Subjective criteria:

Hrutshoola (chest pain),Arohana ayasa (exertional dyspneoa),Pratah shirashoola (early morning headache), Bhrama (Giddiness), Nidra viparyaya(Insomnia), Dourbalya (weakness), Hrudrava (palpitation), Amlodgara (sour belching),Padashopha (pedal oedema), Angamarda (bodyache).


 

 

SI.NO

SYMPTOMS

SEVERITY

GRADE

1.      

Hrutshoola (chest pain)

 

·       No hrutshoola

·       1 or less than once a week, relieves without any intervention

·       2-3 times a week, relieves after mild rest

·       More than 3 times a week, needs medical intervention

·       Persistent

CS

 

CD1

 

CD2

 

CD3

CD4

 

2.      

Arohana ayasa (exertional dyspneoa)

 

·       No arohana ayasa

·       Occurs once a week relieves without any intervention

·       2-3 times a week but does not affect daily routine relieves after rest

·       More than 3 times a week relieves after medical intervention

·       Persistent, no relief at all.

CS

 

CD1

 

CD2

 

CD3

CD4

 

3.      

PratahShirahshoola (early morning headache)

 

·       No Pratah shirashoola

·       Occurs once a week relieves without any intervention

·       2-3 times a week but does not affect daily routine relieves after rest

·       More than 3 times a week relieves after medical intervention

·       Persistent, no relief at all.

CS

 

CD1

 

CD2

 

CD3

CD4

 

4.      

Bhrama (giddiness)

 

·       No bhrama

·       Bhrama occurs once a week relieves without any intervention

·       2-3 times a week but does not affect daily routine relieves after rest

·       More than 3 times a week relieves after medical intervention

·       Persistent, no relief at all.

CS

CD1

 

CD2

 

CD3

 

CD4

 

5.      

Nidraviparyaya

 

·       No nidra viparyaya

·       Once a week, regains sleep,total sleep – 6-8 hours.

·       2-3 times a week,regains sleep after longer time total sleep-less than 6hours.

·       More than 3 times a week total sleep < 4hours

·       Daily, sleep hours<3 hours

 

CS

CD1

 

CD2

 

 

CD3

 

CD4

 

6.      

Dourbalya (weakness)

 

·       No dourbalya

·       Dourbalya occurs once a week relieves without any intervention

·       2-3 times a week but does not affect daily routine relieves after rest

·       More than 3 times a week relieves after medical intervention

·       Persistent, no relief at all.

CS

CD1

 

CD2

 

CD3

 

CD4

 

7.      

Hrudrava (palpitation)

·       No hrudrava

·       Palpitation after heavy physical excercise, subsides with rest does not affect daily routine

·       Palpitations without any physical activity, occurs 1-2 times a week, subsides without medications

·       Palpitations more than 3 times a week, patient on medications

·       Persistent palpitations, no relief with medications.

CS

 

CD1

 

 

CD2

 

 

CD3

 

CD4

8.      

Amlodgara(sour belching)

 

·       No belching

·       Feeling of belching with no sound

·       Feeling of belching with mild sound

·       Feeling of belching with moderate sound

·       Feeling of belching with severe sound

CS

CD1

CD2

CD3

CD4

 

9.      

Padashopha (pedal oedema)

 

·       No pada shotha

·       1 or less than once a week, subsides without any intervention

·       2-3 times a week, subsides after limb elevation, rest etc.

·       More than 3 times a week needs medical intervention

·       Persistent

CS

 

CD1

 

CD2

CD3

 

CD4

 

10.   

Angamarda (Bodyache)

 

·       No angamarda

·       1 or less than once, does not affect daily routine

·       2-3 times a week, relieves after taking rest.

·       More than 3 times a week relieves after taking analgesics

·       Persistent, repeated body aches

CS

 

CD1

 

CD2

 

CD3

CD4

 

 
Close